SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trickle Portfolio

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (1249)10/25/2002 9:27:23 AM
From: tuck  Read Replies (1) of 1784
 
From Briefing.com:

>>8:43AM Invitrogen downgraded at Piper Jaffray (IVGN) 28.70: USB Piper Jaffray downgrades to OUTPERFORM from Strong Buy following last night's results; cites lowered Q4 guidance and worsening issues with the oligonucleotide and genomic service parts of the molecular biology biz; cuts 2003 est to $749 mln/$1.97 and lowers price target to $40 from $42.

8:36AM Applied Bio downgraded at Piper Jaffray (ABI) 19.31: USB Piper Jaffray downgrades to UNDERPERFORM from Mkt Perform, saying better than expected results were driven by gains in mass spec that are unsustainable and which compensated for weakness elsewhere; believes growth over the following year will remain in the single digits.<<

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext